Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

Mersana Therapeutics, Inc. ikhonkco yemakethe

Umthamo wokuthengwa kweempahla Mersana Therapeutics, Inc. namhlanje kunye nembali yentlawulo ye-Mersana Therapeutics, Inc. ukususela ekuqaleni kokuthengisa kwi0M4.F izabelo kwi-stock exchange.
Yongeza kumajethijethi
Ukongezwa kumajethi

Mersana Therapeutics, Inc. i-capital capital

Namhlanje i-market capital Mersana Therapeutics, Inc. ingu-473 741 856 Euro.
-135 751 968 € (-22.27%)
utshintsho lwentengo ukususela ngezolo

Yintoni i capitalism ye Mersana Therapeutics, Inc. namhlanje. Mersana Therapeutics, Inc. ingxowankulu ulwazi oluvulekileyo. Olu lwazi lolwazi malunga Mersana Therapeutics, Inc. capitalization. Mersana Therapeutics, Inc. i-cap cap namhlanje ilingana no-473 741 856 iidola zaseMelika.

Mersana Therapeutics, Inc. ivolumu yezorhwebo

Namhlanje inani lemali yokuthengisa Mersana Therapeutics, Inc. lingama-1 015 Euro.

Mersana Therapeutics, Inc. ivolumu yokurhweba namhlanje ikho 1 015 iidola zaseMelika. Namhlanje, Mersana Therapeutics, Inc. kwenzeke kwiimarike ezahlukeneyo zesitokhwe. Itshathi yemihla ngemihla yokurhweba ye Mersana Therapeutics, Inc. ikwiwebhusayithi yethu. Mersana Therapeutics, Inc. ikhonkco yentengiso yehla.

Bonisa:
Ukuze

Mersana Therapeutics, Inc. istatshi yekhredithi yemakethe

Mersana Therapeutics, Inc. itshathi yemalike yeminyaka ngeminyaka. Kwiveki yonke, Mersana Therapeutics, Inc. capitalisation itshintshwe ngu -21.77%. 0% ngenyanga - utshintsho kwimali eyenziweyo Mersana Therapeutics, Inc.. Namhlanje, Mersana Therapeutics, Inc. capitalization ilingane 473 741 856 iidola zaseMelika.

Iveki Inyanga iinyanga 3 Unyaka Iminyaka emithathu

Mersana Therapeutics, Inc. imbali yenkxaso-mali

Umhla Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
13/03/2023 473 741 856 €
10/03/2023 609 493 824 €
09/03/2023 607 168 832 €
08/03/2023 619 600 192 €
07/03/2023 565 849 792 €
06/03/2023 605 435 968 €
03/03/2023 605 545 472 €

Mersana Therapeutics, Inc. isatifiketi somqulu

Iveki Inyanga iinyanga 3 Unyaka Iminyaka emithathu

Mersana Therapeutics, Inc. idatha yembali yevolumu

Umhla Umqulu (24h)
Ixabiso lezorhwebo leMersana Therapeutics, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-0M4.F ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
13/03/2023 1 015 €
10/03/2023 1 015 €
09/03/2023 1 015 €
08/03/2023 1 015 €
07/03/2023 1 015 €
06/03/2023 1 015 €
03/03/2023 1 015 €

Mersana Therapeutics, Inc. capitalised eyi- 473 741 856 Iidola zaseMelika ku- 13/03/2023. 10/03/2023 Mersana Therapeutics, Inc. capitalization ilingane 609 493 824 iidola zaseMelika. Mersana Therapeutics, Inc. capitalization e 09/03/2023 ifikelele kuthi 607 168 832 iidola zaseMelika. Mersana Therapeutics, Inc. capitalised eyi- 619 600 192 Iidola zaseMelika ku- 08/03/2023.

Mersana Therapeutics, Inc. i-capitalisation yentengiso kwi 07/03/2023 ilingana ne 565 849 792 iidola zaseMelika. Vuliwe 06/03/2023, Mersana Therapeutics, Inc. capitalisation yayiyi- $ 605 435 968. Iimali yentengiso enkulu ye Mersana Therapeutics, Inc. kwi 03/03/2023 ifikelele kuthi 605 545 472 iidola zaseMelika.

Inkcitho ye-Mersana Therapeutics, Inc. namhlanje ngu-473 741 856 €. Iimali zentengiso ye-Mersana Therapeutics, Inc. ishintshile -22.273% xa kuthelekiswa nezolo. Imali yokuthengisa ye 0M4.F izabelo ze Mersana Therapeutics, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-1 015 €. Ixabiso lokuthengiswa kwezabelo ze Mersana Therapeutics, Inc. latshintshile kwi-0% xa kuthelekiswa nosuku lwangaphambili lworhwebo.

Iindleko zezabelo Mersana Therapeutics, Inc.

YezeMali Mersana Therapeutics, Inc.